Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
- Authors
- Choi, K. M.; Yoo, H. J.; Kim, H. Y.; Lee, K. W.; Seo, J. A.; Kim, S. G.; Kim, N. H.; Choi, D. S.; Baik, S. H.
- Issue Date
- 6-Feb-2009
- Publisher
- ELSEVIER IRELAND LTD
- Keywords
- Type 2 diabetes; esRAGE; Inflammation; Arterial stiffness; Cardiovascular disease
- Citation
- INTERNATIONAL JOURNAL OF CARDIOLOGY, v.132, no.1, pp.96 - 101
- Indexed
- SCIE
SCOPUS
- Journal Title
- INTERNATIONAL JOURNAL OF CARDIOLOGY
- Volume
- 132
- Number
- 1
- Start Page
- 96
- End Page
- 101
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/120583
- DOI
- 10.1016/j.ijcard.2007.10.047
- ISSN
- 0167-5273
- Abstract
- Background: Advanced glycation end products (AGEs) and its receptor (RAGE) were known to play a pivotal role in the development of cardiovascular complications of diabetes. We investigated the association between circulating endogenous secretory RAGE (esRAGE) levels, inflammatory markers and arterial stiffness measured using brachial-ankle pulse wave velocity (baPWV). Methods: The study subjects were composed of 76 type 2 diabetic patients and 78 age- and sex-matched non-diabetic subjects. Results: Circulating esRAGE levels were significantly lower in subjects with type 2 diabetes (0.237 +/- 0.123 ng/ml vs. 0.307 +/- 0.177 ng/ml, p=0.005), and those levels were inversely correlated with body mass index (BMI), waist circumference, blood pressure, triglyceride, fasting glucose level and insulin resistance. Furthermore, esRAGE levels were significantly associated with adiponectin (r=0.164, p=0.044), interleukin-6 (IL-6) (r=-0.242, p=0.009) levels and baPWV (r=-0.296, p<0.001). Multiple regression analysis showed that fasting insulin, IL-6, glucose level and insulin resistance are major factor determining esRAGE (R-2=0.186). Moreover, baPWV was found to be associated with age, systolic blood pressure, triglyceride, sex, BMI, fasting insulin and esRAGE level (R-2=0.583). Conclusions: Circulating esRAGE levels were significantly lower in type 2 diabetic patients, and were associated with inflammation and arterial stiffness. These results suggest that esRAGE may play an important role on ligand-RAGE interaction propagated inflammation and atherosclerosis. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
- Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.